Insufficient scRNA-seq data for expression of ALX1 at single-cell level.
Insufficient scRNA-seq data for expression of ALX1 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
skin | 97% | 36.92 | 1751 / 1809 | 96% | 50.19 | 452 / 472 |
uterus | 95% | 58.65 | 161 / 170 | 25% | 4.45 | 113 / 459 |
eye | 0% | 0 | 0 / 0 | 100% | 77.48 | 80 / 80 |
kidney | 92% | 154.88 | 82 / 89 | 7% | 0.39 | 61 / 901 |
bladder | 81% | 27.05 | 17 / 21 | 15% | 1.30 | 78 / 504 |
ovary | 69% | 28.11 | 124 / 180 | 17% | 1.26 | 72 / 430 |
breast | 62% | 14.98 | 284 / 459 | 5% | 0.35 | 58 / 1118 |
blood vessel | 61% | 20.29 | 813 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 58% | 3.84 | 26 / 45 |
prostate | 33% | 4.42 | 81 / 245 | 8% | 0.43 | 42 / 502 |
esophagus | 13% | 1.39 | 191 / 1445 | 28% | 1.88 | 51 / 183 |
thymus | 39% | 4.54 | 254 / 653 | 0% | 0.05 | 3 / 605 |
adipose | 36% | 6.97 | 436 / 1204 | 0% | 0 | 0 / 0 |
lung | 15% | 1.86 | 89 / 578 | 19% | 1.44 | 217 / 1155 |
brain | 13% | 1.22 | 352 / 2642 | 2% | 0.32 | 17 / 705 |
stomach | 6% | 0.53 | 20 / 359 | 8% | 0.35 | 24 / 286 |
intestine | 7% | 0.62 | 65 / 966 | 7% | 0.34 | 35 / 527 |
muscle | 7% | 0.56 | 56 / 803 | 0% | 0 | 0 / 0 |
adrenal gland | 5% | 0.57 | 12 / 258 | 1% | 0.03 | 2 / 230 |
heart | 5% | 0.45 | 46 / 861 | 0% | 0 | 0 / 0 |
liver | 0% | 0 | 0 / 226 | 5% | 0.34 | 20 / 406 |
pancreas | 1% | 0.09 | 4 / 328 | 3% | 0.34 | 6 / 178 |
peripheral blood | 0% | 0.07 | 4 / 929 | 0% | 0 | 0 / 0 |
spleen | 0% | 0.03 | 1 / 241 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 29 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 1 |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0048704 | Biological process | embryonic skeletal system morphogenesis |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_0045892 | Biological process | negative regulation of DNA-templated transcription |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0016604 | Cellular component | nuclear body |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0000785 | Cellular component | chromatin |
GO_0005634 | Cellular component | nucleus |
GO_1990837 | Molecular function | sequence-specific double-stranded DNA binding |
GO_0000981 | Molecular function | DNA-binding transcription factor activity, RNA polymerase II-specific |
GO_0001228 | Molecular function | DNA-binding transcription activator activity, RNA polymerase II-specific |
GO_0005515 | Molecular function | protein binding |
GO_0000977 | Molecular function | RNA polymerase II transcription regulatory region sequence-specific DNA binding |
Gene name | ALX1 |
Protein name | ALX homeobox protein 1 (Cartilage homeoprotein 1) (CART-1) |
Synonyms | CART1 |
Description | FUNCTION: Sequence-specific DNA-binding transcription factor that binds palindromic sequences within promoters and may activate or repress the transcription of a subset of genes . Most probably regulates the expression of genes involved in the development of mesenchyme-derived craniofacial structures. Early on in development, it plays a role in forebrain mesenchyme survival . May also induce epithelial to mesenchymal transition (EMT) through the expression of SNAI1 . . |
Accessions | ENST00000316824.4 Q15699 |